The AI Revolution in Drug Development with Jennifer Bittinger, President and Co-founder of Narrativa
Description
From TV production to trailblazing in generative AI, Jennifer Bittinger’s journey is anything but ordinary. In this episode of Inside Biotech, Jennifer shares how her non-linear career path–from helping launch Hulu to leading Narrativa–prepared her to bring AI innovation into the life sciences. She reveals how Narrativa became the first company to have FDA-approved, AI-generated clinical trial documentation, cutting years of “white space” in the drug-development process. Along the way, she tackles fears about AI replacing jobs, explaining how it can instead give scientists and medical writers their time back for high-value work. Today’s episode is a masterclass in how relationships, curiosity, and a little bit of courage can transform entire industries.
Follow our Instagram @insidebiotech for updates about episodes and upcoming guests!
To learn more about BCLA’s events and consulting visit our website.
Follow BCLA on LinkedIn
United States
